Illinois Biotechnology Innovation Organization (iBIO)

Thrilled to see the continued success of MAIA Biotechnology, Inc., one of our outstanding iBIO community members! Their recent announcement of promising interim results for THIO in advanced non-small cell lung cancer is truly exciting. MAIA's innovative approach to targeted cancer immunotherapy showcases the cutting-edge research happening right here in Illinois. These developments not only drive our biotech ecosystem forward but, more importantly, offer hope to patients battling this challenging disease. Congratulations to Dr. Vlad Vitoc and the entire MAIA team on this significant milestone. Your dedication to improving patient lives through groundbreaking science exemplifies the mission we all share in the life sciences industry. Looking forward to seeing what's next for MAIA and the potential impact of THIO on cancer treatment. This is exactly the kind of innovation and progress that makes me proud to be part of Illinois' thriving biotech community. Read more: https://lnkd.in/gnkTBsHq Stay updated on community and industry news, subscribe to our daily NewsBrief: https://lnkd.in/g58aVNUw #IllinoisInnovation #BiotechBreakthrough #CancerResearch #PatientImpact

?? Prost! Join iBIO for an Oktoberfest-style Happy Hour ?? Date: September 25th? Sponsored by: Element CG, a CG Life Company It's time to celebrate Oktoberfest with your fellow biotech professionals.?What's on tap:?- Bavarian brats?- Fresh-baked pretzels?- A selection of seasonal beers?- Invaluable networking opportunities Don't miss this chance to raise a stein, expand your network, and enjoy some German-inspired festivities.?RSVP now to secure your spot at the biergarten! https://lnkd.in/gUHKrcCQ #iBIO #Oktoberfest #Networking #BiotechCommunity

Brace yourselves for a brand new weekly NewsBrief quiz – and I'll warn you, it's not for the faint of heart! I've crafted some truly challenging questions to test even our most knowledgeable biotech buffs. One lucky winner will take away our grant prize for this week. But you’ve got to get all five questions right..do you think you have what it takes? Start the quiz now: https://lnkd.in/gZvVS68B Didn't score well on the quiz? Subscribe to the NewsBrief and get a leg up on the competition: https://lnkd.in/g58aVNUw

?? Urgent: The Rare Pediatric Disease Priority Review Voucher program is set to expire on Sept 30, 2024! iBIO was happy to join our other Council of State Bioscience Associations (CSBA) partners in signing a letter to Congress urging reauthorization. ?? Why it matters: - 53 vouchers awarded for 39 rare pediatric diseases - 36 diseases had no previous treatments - Over 200,000 patients benefited iBIO President & CEO John Conrad: "The RPD PRV program is crucial for developing therapies for our most vulnerable patients. We urge Congress to act swiftly to renew this program." Join us in supporting the Creating Hope Reauthorization Act. Let's keep driving innovation for rare pediatric diseases! Learn more: https://lnkd.in/gx5EUdMg #RareDiseases #Biotech #Healthcare #CongressAct #CSBA

A big congratulations to 32 Biosciences "Three Squared" on emerging from stealth mode! ?? It's thrilling to see another innovative company in our ecosystem take this significant step forward. Your work in gut microbiome medicine promises to push the boundaries of healthcare and biotechnology. These are truly exciting times for our community. The continued growth and emergence of companies like 32 Biosciences showcase the vibrant innovation happening right here in Illinois. To the entire team at 32 Biosciences, including CEO Peter Farmakis: Well done on reaching this milestone! We're eager to see how your contributions will shape the future of healthcare and our biotech landscape. Learn more about 32 Biosciences: https://lnkd.in/g6Wyx2HM #IllinoisBiotech #InnovationCelebration #BiotechGrowth #CommunitySuccess #IllinoisBiotech #HealthInnovation #GutHealth #MicrobiomeMedicine #BiotechBreakthrough

Special NewsBrief Feature: Laughing in the Face of Pain: Amy and Pat Tomasulo’s Fight Against Trigeminal Neuralgia In our latest Innovation Insights feature, we spotlight Amy Tomasulo, who's revolutionizing her approach to managing trigeminal neuralgia, one of the most severe pain conditions known to medicine. Key facts about trigeminal neuralgia: - Rare neurological disorder affecting approximately 400,000 Americans - Characterized by extreme, shock-like facial pain - Often triggered by routine activities such as eating or speaking Amy and her husband Pat have developed an unconventional coping mechanism: comedy. By transforming laughter from a potential pain trigger into a powerful management tool, they're challenging traditional approaches to chronic pain treatment. This inspiring story showcases the potential for patient-driven innovation in healthcare. It reminds us that sometimes, the most effective solutions come from unexpected sources. Read the full article: https://lnkd.in/gfPN8YnV Buy Tickets to Laugh Your Face Off: https://lnkd.in/g346TG3Q Check out the online auction: https://lnkd.in/gbbKUePt #TrigeminalNeuralgia #HealthcareInnovation #PatientEmpowerment #ChronicPainManagement

iBIO proudly welcomes Immedica Pharma to Chicago! ????? We're excited to see Immedica establish their U.S. commercial business in our thriving life sciences ecosystem. Their dedication to rare and severe diseases aligns perfectly with our community's mission. About Immedica: - Focused on genetic & metabolic diseases, hematology & oncology, and specialty care - Serves patients in over 50 countries - Bringing innovative therapies to address unmet medical needs John Conrad, iBIO President and CEO, shares: "We're thrilled to welcome Immedica to Chicago. Their focus on rare diseases aligns perfectly with our community's commitment to supporting patients and families affected by these conditions. Immedica's presence here will not only bring new treatment options but also contribute to the ecosystem of support and advocacy we've built for rare disease communities." Immedica's expertise in marketing, sales, pharmacovigilance, and medical affairs strengthens our local rare disease capabilities. Together, we're advancing hope and innovation for patients with rare and severe conditions! ?? Read more: https://lnkd.in/g8k79hqG This article was originally published on iBIO NewsBrief. Gain a head start on your day with iBIO NewsBrief. Subscribe to receive top industry headlines delivered straight to your inbox: https://lnkd.in/g58aVNUw #WelcomeImmedica #RareDiseases #ChicagoLifeSciences #PatientCare #GeneticDiseases #Hematology #Oncology

?? Element CG, a CG Life Company and iBIO invite you to raise a glass and yell "Prost!" at our Oktoberfest Networking Happy Hour on September 25th. RSVP required to join this festive celebration of biotech and beer. Register: https://lnkd.in/gJt_nf-x

Governor JB Pritzker has released a five-year economic growth plan that recognizes life sciences as a key growth industry for our state. At iBIO, we're thrilled to see this focus on an industry that's not only driving economic growth but also improving lives. Key highlights: - Life sciences in Illinois is growing faster than the average of all private industries - The plan includes targeted initiatives to support our industry's continued expansion - Emphasis on both economic benefits and the impact on patient care As John Conrad, iBIO President and CEO, notes: "Incentivizing the growth of the life sciences industry is more than just jobs; its impact on improving and extending patients' lives is an even better and higher goal." We're looking forward to collaborating with the Governor's office, DCEO, and Intersect Illinois to further strengthen our thriving life sciences ecosystem. Read the full plan: https://lnkd.in/gFyFMKsu What aspects of this initiative excite you most? Share your thoughts below! ?? #LifeSciences #IllinoisInnovation #EconomicGrowth #Biotechnology

Friday Biotech Blitz: Challenge Your Scientific Acumen ???? Calling all biotech buffs! Our weekly iBIO NewsBrief Quiz is here to test your grasp of the latest breakthroughs. This week's lineup: * 5 cutting-edge questions * 1 chance to prove your expertise * Top scorer earns bragging rights Ready to dive into the molecular frontier? Flex your mental muscles and see how you measure up in this rapid-fire roundup of recent innovations. Remember, precision is as crucial here as it is in the lab. Good luck, and may your scientific instincts prevail! ???? Start the quiz now: https://lnkd.in/gp_qrNbE Want a jump start on the competition to win our weekly prize? Subscribe to the NewsBrief and get the link first thing in the morning: https://lnkd.in/g58aVNUw